Пролактинома Препараты

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Astellas Pharma

Astellas Pharma to acquire Propella Therapeutic...

FDA Grants Full Approval for Astellas Pharma's ...

Japan's Astellas sees cancer drug fueling 29% p...

Astellas introduces sustainable community initi...

Astellas Pharma: A Contrarian Investment (OTCMK...

Astellas Pharma - Global Web Site on Behance

Astellas Pharma EMEA celebrates its 10th annive...

US FDA approves Astellas Pharma pill for menopa...

Astellas Pharma Joins Record Bond Sales by Japa...

FDA Approves Astellas’ Non-hormonal Menopause T...

Astellas Home page | Astellas Pharma Inc.

Home | Astellas Pharma Canada, Inc.

Astellas Home page | Astellas Pharma Inc.

FDA blocks Astellas’ Claudin cancer drug over m...

Атлас лекарственных растений - YouTube

Astellas Pharma Projects :: Photos, videos, log...

Asia Business Daily on Twitter: "Astellas Pharm...

Astellas gets FDA priority review for gastric c...

Astellas Pharma Inc. (4503N.MX) stock price, ne...

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Pharmaceutical Technology

China Formally Arrests Japanese Employee of Dru...

Главная | Astellas Pharma Russia

Главная | Astellas Pharma Russia

Astellas Sues Over New Myrbetriq Patent to Reca...

Astellas

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas' Prostate Cancer Drug Available In Jap...

About | Astellas Pharma Ltd

Astellas licenses 4DMT’s AAV vector for ophthal...

Astellas Offloads 5 Legacy Products to Germany’...

Astellas, University of Tokyo extend partnershi...

Astellas Pharmaceuticals Establishes Open Innov...